<p>&nbsp;</p>
<table style="border-color: #5c5d5b; border-width: 1px; border-style: solid;" border="1" cellpadding="5">
<tbody>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">8:00-9:30</td>
<td colspan="3" bgcolor="#FFCC66" valign="top">Registration</td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">09:30 - 10:10<br />Plenary Session:<br /><strong>Chair: <br />Avi Treves</strong></td>
<td colspan="3" bgcolor="#FFF0D2" valign="top"><img style="margin: 10px; float: left;" alt="Caplan 2012" src="/images/Caplan_2012.jpg" height="75" width="61" /><strong><a href="/israstem-abs/out_of_pdf/adultmscsth_Arnold_Caplan.pdf" target="_blank">Adult MSCs: The New Medicine </a></strong><br /><span style="color: #ff6600;"><strong>Arnold Caplan</strong></span><em><br />Biology, Case Western Reserve University, Cleveland, USA</em><br /><em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em><em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">10:10 - 10:40</td>
<td colspan="2" bgcolor="#FFFF99" valign="top">Coffee break</td>
</tr>
<tr bgcolor="#FFCC66">
<td colspan="3" bgcolor="#99CC00" height="3" nowrap="nowrap"></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">10:40-12:20</td>
<td bgcolor="#E4E9D8" valign="top" width="50%">
<div>
<div><span><strong><strong><em><img style="margin-left: 10px; margin-right: 10px; float: left;" alt="Yehudit Cohen Sheba Tissue Banks" src="/images/Israstem13/Yehudit_Cohen_Sheba_Tissue_Banks.jpg" height="78" width="56" /></em>Session E:</strong><br />Translational Research &amp; Bio Banking</strong><br /><strong><span style="color: #ff6600;">Chair: Yehudit Cohen</span><em><br /></em></strong><em>Scientific Director - Institutional Tissue Banks, Sheba Medical Center, Israel<br /><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></span></div>
</div>
<em></em></td>
<td bgcolor="#E4E9D8" valign="top" width="50%"><strong><strong><img style="margin-left: 10px; margin-right: 10px; float: left;" alt="אריק חסון" src="/images/Israstem13/%D7%90%D7%A8%D7%99%D7%A7_%D7%97%D7%A1%D7%95%D7%9F.jpg" height="77" width="55" />Session F:</strong><br />Supporting Environment </strong><br /><span style="color: #ff6600;"><strong>Chair: Arik Hasson</strong></span><em><br /> Executive VP, Research &amp; Development, Kadimastem Ltd., Israel<br /><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">
<p><span>10:40 - 11:00</span> <span>&nbsp;</span></p>
<p><span><strong>Keynote</strong><br /><strong> Lectures</strong><br /><br /></span></p></td>
<td bgcolor="#FFF0D2" valign="top"><strong><a href="/israstem-abs/out_of_pdf/stemcellderiv_Marcelle_Machluf.pdf" target="_blank">Stem Cell Derived Nano-Vesicles, a New Platform Targeting the Tumor Bed </a></strong><br /><span style="color: #ff6600;"><strong>Marcelle Machluf</strong> </span><br /><em>Faculty of Biotechnology and Food Engineering, Institute of Technology, Haifa, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></td>
<td bgcolor="#FFF0D2" valign="top"><strong><a href="/israstem-abs/out_of_pdf/bringingcellt_Dirk_Balshuesemann.pdf" target="_blank">Bringing Cell Therapies into Clinical Routine</a></strong><br /><span style="color: #ff6600;"><strong>Dirk Balshuesemann</strong></span><em><br />Clinical Business, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany<br /><em><img src="http://isranalytica.org.il/images/DE-flag.gif" height="23" width="35" /></em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">11:00 - 11:20</td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/humanumbilical_Arnon_Nagler.pdf" target="_blank">Human Umbilical Cord Blood: More than a Source of Hematopoietic Stem Cells: Neurological Potential</a><br /><span style="color: #ff6600;">Arnon Nagler</span><br /></strong><em>Chaim Sheba Medical Center, Ramat Gan, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em><br /></em></td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/buildingbridge_Thomas_Fellner.pdf" target="_blank">Building Bridges from Research to Therapy: Enabling the Utilization of Human Induced Pluripotent Stem Cells for Clinical Therapies</a></strong><br /><span style="color: #ff6600;"><strong>Thomas Fellner</strong></span><em><br />Pluripotent Stem Cell Innovation Center, Lonza, Inc., Walkersville, USA<br /><em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">11:20 - 11:40</td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/theroleofplu_Nissim_Benvenisty.pdf" target="_blank">The Role of Pluripotent Stem Cells in Modeling Human Disorders and in Drug Screening</a><br /><span style="color: #ff6600;">Nissim Benvenisty</span><br /></strong><em>Stem Cell Unit, Genetics, Hebrew University, Jerusalem, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em><br /></em></td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/currentregulat_Alan__Moore.pdf" target="_blank">Current Regulatory and cGMP Compliance Trends for Cellular Therapeutics and the Challenges in </a></strong><a href="/israstem-abs/out_of_pdf/currentregulat_Alan__Moore.pdf"><strong>Translation to Late-Stage Commercial-Ready Manufacturing</strong></a><strong></strong><br /><span style="color: #ff6600;"><strong>Alan Moore<em><br /></em></strong></span><em>VP Testing and Cell Services, WuXi AppTec&nbsp; Philadelphia, USA<br /><em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">11:40 - 12:00</td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/buildingqualit_Katheryn_Shea.pdf" target="_blank">Building Quality Biological Collections to Maximize Use</a><br /><span style="color: #ff6600;">Katheryn Shea</span><br /></strong><em>Precision Bioservices, Inc., Frederick, USA<br /><em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em><br /></em></td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/intellectualpr_Hadassa_Waterman.pdf" target="_blank">Intellectual Property Issues Related to </a></strong><a href="/israstem-abs/out_of_pdf/intellectualpr_Hadassa_Waterman.pdf"><strong>Cell-Based Inventions</strong></a><strong></strong><br /><strong><span style="color: #ff6600;">Hadassa Waterman</span><em><br /></em></strong><em>Biotech, Ehrlich and Fenster, Ramat Gan, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">12:00 - 12:20</td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/ipsstemcellb_Ida_Biunno.pdf" target="_blank">IPS Stem Cell Banking</a><br /><span style="color: #ff6600;">Ida Biunno</span><br /></strong><em>IRGB, IRGB-CNR, Milan, Italy<br /><em><em><img src="http://isranalytica.org.il/images/italy-flag.jpg" alt="italy" height="23" width="35" /></em></em><br /></em></td>
<td valign="top"><strong><a href="/israstem-abs/out_of_pdf/stemcellsinp_Judith_Ben-Porath.pdf" target="_blank">Stem Cells in Preclinical Studies: Choosing the </a></strong><a href="/israstem-abs/out_of_pdf/stemcellsinp_Judith_Ben-Porath.pdf"><strong>Optimal Animal Model</strong></a><br /><strong><span style="color: #ff6600;">Judith Ben-Porath</span><em><br /></em></strong><em>Pharmaseed, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em><br /></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">12:20 - 14:00</td>
<td colspan="3" bgcolor="#FFFF99" valign="top">Lunch break</td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">14:00 - 14:40<br />Plenary Session:<br /><span style="color: #000000;"><strong>Chair: <br />Avi Treves</strong></span></td>
<td colspan="3" bgcolor="#FFF0D2" valign="top"><span><img style="margin: 10px; float: left;" alt="ZE photo" src="/images/Israstem13/ZE_photo.jpg" height="84" width="60" /></span> <strong><a href="/israstem-abs/out_of_pdf/thet-bodyappr_Zelig_Eshhar.pdf" target="_blank">The T-Body Approach: From the Mouse Cage to The Patient’s Bed</a></strong><br /><span style="color: #ff6600;"><strong>Zelig Eshhar</strong></span><em colspan="3" bgcolor="#FFF0D2"> <br />Immunology, Weizmann Institute, Rehovot, Israel</em><br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em><strong><br /></strong><em><em><em></em></em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">14:40 - 15:10</td>
<td colspan="2" bgcolor="#FFFF99" valign="top">Coffee break</td>
</tr>
<tr bgcolor="#99CC00">
<td colspan="3" height="3" nowrap="nowrap"></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">15:10-16:30</td>
<td bgcolor="#E4E9D8" valign="top"><p><strong><em><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em>Session G:</strong><br />
    Funding<strong><br>
    Chair: Anat Naschitz</strong> <br>
    Managing Director, OrbiMed Advisors, LLC<em><br style="margin: 10px; float: left;" alt="IMG 2381" src="/images/Israstem13/IMG_2381.JPG" height="75" width="58" />
    </em></p>  </td>
<td colspan="2" bgcolor="#E4E9D8" valign="top"><strong><strong><strong><strong><img style="margin: 10px; float: left;" alt="IMG 2381" src="/images/Israstem13/IMG_2381.JPG" height="75" width="58" />Session H:</strong><br />Company-Regulator Interface <br /><span style="color: #ff6600;">Chair: Ofra Axelrod</span><br /></strong><em>Deputy Director, The Institute for Standardization and Control of Pharmaceuticals, Israeli MOH, Israel<br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></strong></strong><em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap"><span>15:10 - 15:30</span> <span><br /><strong>Keynote</strong><br /><strong> Lectures</strong></span></td>
<td bgcolor="#FFF0D2" valign="top">
<p><strong>The Office of the Israel Chief Scientist Incentives for R&amp;D in Cell Therapy, Regenerative Medicine and Stem Cells</strong><br />
  <span style="color: #ff6600;"><strong>Janette Lazarovits</strong></span><br />
  <em>The Office of the Chief Scientist</em></p></td>
<td colspan="2" rowspan="4" valign="top" bgcolor="#FFFFFF"><p><span><strong><a href="/israstem-abs/out_of_pdf/theregulatory_Margarida__Menezes_Ferreira.pdf" target="_blank">The Regulatory Challenges for the Approval of Advanced Therapies in Europe </a></strong><br />
      <span style="color: #ff6600;"><strong>Margarida Menezes Ferreira</strong></span><br />
    <em>Medicines Evaluation Department, INFARMED,</em><br />
    <em>National Authority of Medicines and Health Products, Lisboa, Portugal</em><br />
    <em>Member of the Committee for Advanced Therapies and of the Biologics Working Party/CHMP – EMA, Portugal</em> <br />
    <span style="color: #ff6600;" color="#FF6600"><span style="font-family: verdana,geneva; font-size: x-small;" face="verdana,geneva" size="2"><i><img title="7628969_flagbig1.gif" alt="7628969_flagbig1.gif" src="http://dr.doali.co.il/admin/temp/newsletters/1006/7628969_flagbig1.gif" height="23" width="35" /></i></span></span><br />
    <br />
    <strong><a href="/israstem-abs/out_of_pdf/fdaisitrea_Joyce_Frey-Vasconcells.pdf" target="_blank">FDA: Is it Really a Black Hole?</a></strong><br />
    <span style="color: #ff6600;"><strong>Joyce Frey-Vasconcells</strong></span><br />
    <em>Frey-Vasconcells Consulting, LLC</em></span> <span><br />
    </span></p>
  <p><span><br />
        <strong><a href="/israstem-abs/out_of_pdf/euregulators_Anne__Dupraz-Poiseau.pdf" target="_blank">EU Regulators’ Expectations for a Stem Cell Based Product Development a Focus on CMC and NC Development</a></strong><br />
    <strong><span style="color: #ff6600;">Anne Dupraz-Poiseau</span></strong><br />
    <em>Voisin Consulting Life Sciences, France<br />
      <em><em><img src="/images/frlarge.gif" alt="france" height="23" width="34" /></em></em></em></span></p>
  <p><strong>A Harmonized Approach in Regulation of PLX-PAD<em><br />
    </em><span style="color: #ff6600;">Racheli Ofir</span><em><br />
    </em></strong><em>Pluristem, MATAM&nbsp; Park, Haifa, Israel (15 min.)</em></p>
  <p><span><em><em><em></em></em><em><em><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></em><br />
    </em></span> <span><strong>&nbsp;</strong></span> <span><strong>&nbsp;</strong></span> <span><strong><span style="color: #ff6600; font-size: 12pt;"><br />
    </span></strong></span></p>
  <p><span><strong><span style="color: #ff6600; font-size: 12pt;">&nbsp;</span></strong></span></p>
  <p><span><strong><img style="float: left;" alt="104714569" src="/images/icons/104714569.jpg" height="76" width="96" /></strong></span><span><strong><span style="color: #ff6600; font-size: 12pt;">Special Panel-Meet the Regulator: <br />
    Audience Questions and Open Discussion</span><br />
  </strong></span> <strong></strong><strong></strong><strong></strong></p>  <p><em><br />
  </em></p></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">15:30 - 15:50</td>
<td bgcolor="#FFFFFF" valign="top"><strong>Pontifax, Vision and Investment Strategy</strong><br />
  <strong><span style="color: #ff6600;">Silvia Noiman</span><em><br />
  </em></strong><em>Pontifax, Israel<br />
  <em><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">15:50 - 16:10</td>
<td bgcolor="#FFFFFF" valign="top"><strong><a href="/israstem-abs/out_of_pdf/syndicateinnov_Alain_Vertes.pdf" target="_blank">Syndicate Innovation Venturing</a></strong><br />
  <span style="color: #ff6600;"><strong>Alain Vertes</strong></span><em> <br />
  Park BioVentures, New York, NY, USA<br />
  <em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">16:10 - 16:30</td>
<td bgcolor="#FFFFFF" valign="top"><a target="_blank" href="/israstem-abs/out_of_pdf/theisraelicel_Avi__Treves_.pdf"><strong>The Israeli Cell Therapy Landscape</strong></a><br />
  <span style="color: #ff6600;"><strong>Avi Treves</strong></span><em><br />
Sheba Cancer Research Center, Israel<br />
<em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">16:30 – 17:10<br>
  Plenary session<strong>:<br>
  <span style="color: #ff6600;">Chair: <br>
  Michel Revel</span></strong></td>
<td colspan="3" valign="top"><span><img style="margin: 10px; float: left;" alt="EvaFeldman-BannerPhoto" src="/images/Israstem13/EvaFeldman-BannerPhoto.jpg" height="83" width="61" /></span><strong><a href="/israstem-abs/out_of_pdf/intraspinalste_Eva_Feldman,_MD,_PhD.pdf">Intraspinal Stem Cell Transplantation in ALS: Results of the First Phase 1 FDA Clinical Trial</a><br /><span style="color: #ff6600;">Eva Feldman&nbsp;</span> <br /></strong><em>Neurology University of Michigan, Ann Arbor, USA</em><br /><em><strong><img src="http://isranalytica.org.il/images/US-flag.gif" alt="USA" height="20" width="35" /></strong></em><em><br /></em><em></em></td>
</tr>
<tr>
<td bgcolor="#FFCC66" nowrap="nowrap">17:10 – 17:25</td>
<td colspan="3" valign="top"><strong><img style="margin: 10px; float: left;" alt="Shosh Merchav" src="/images/Shosh_Merchav.jpg" height="81" width="64" />Closing<br /><span style="color: #ff6600;"> Shosh Merchav</span><br /></strong><em>CEO, Multifacet Biosolutions Ltd., <em>Israel, </em>Co- Chairman Israstem 2013 <br /><em><em><img alt="Israel" src="http://isranalytica.org.il/images/israel-flag.gif" height="25" width="35" /></em></em></em></td>
</tr>
</tbody>
</table>